A Phase I clinical trial, using a structurally related analog of the compound, is currently enrolling patients.
Demsky joined the University of Michigan Rogel Cancer Center communications team in 2019. Prior to that he served as director of communications for the University of Michigan's Life Sciences Institute and science editor for Medicine at Michigan Magazine. Contact: email@example.com
U-M researchers are shedding new light on the ways in which two omnipresent proteins can influence the fate of stem cells during development — with exciting implications for research and health.
Research suggests the possibility of a more general phenomenon, applicable to the growth of other primary cell types.
In mouse models, the work uncovers a new potential target to improve immunotherapy approaches to the deadly disease.
Proof-of-concept research points to wearable monitors’ potential to offer low-cost, non-invasive way to detect this dangerous bone-marrow transplant complication.